Pressure Biosciences Inc
(PBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 741 | 607 | 144 | 498 | 480 |
| Cost of Goods | 359 | 1,271 | 126 | 302 | 314 |
| Gross Profit | 382 | -664 | 18 | 196 | 166 |
| Operating Expenses | 4,378 | 1,154 | 1,507 | 1,400 | 1,566 |
| Operating Income | -3,638 | -1,547 | -1,363 | -902 | -1,086 |
| Interest Expense | 3,894 | 3,990 | 2,034 | 1,836 | 2,579 |
| Other Income | 674 | 1,078 | -1,065 | -179 | -574 |
| Pre-tax Income | -6,858 | -4,458 | -4,462 | -2,916 | -4,240 |
| Net Income Continuous | -6,858 | -4,458 | -4,462 | -2,916 | -4,240 |
| Net Income | $-6,858 | $-4,458 | $-4,462 | $-2,916 | $-4,240 |
| EPS Basic Total Ops | -0.46 | -0.37 | -0.44 | -0.32 | -0.48 |
| EPS Basic Continuous Ops | -0.43 | -0.34 | -0.40 | -0.28 | -0.44 |
| EPS Diluted Total Ops | -0.46 | -0.37 | -0.44 | -0.32 | -0.48 |
| EPS Diluted Continuous Ops | -0.43 | -0.34 | -0.40 | -0.28 | -0.44 |
| EPS Diluted Before Non-Recurring Items | -0.46 | -0.37 | -0.44 | N/A | N/A |
| EBITDA(a) | $-2,995 | $-1,495 | $-1,037 | $-235 | $-233 |